These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9611845)

  • 41. Microspheres of alginate-chitosan containing isoniazid.
    Lucinda-Silva RM; Evangelista RC
    J Microencapsul; 2003; 20(2):145-52. PubMed ID: 12554370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mathematical modeling and optimization of drug delivery from intratumorally injected microspheres.
    Tzafriri AR; Lerner EI; Flashner-Barak M; Hinchcliffe M; Ratner E; Parnas H
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):826-34. PubMed ID: 15701873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.
    Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS
    J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Morphological reactions in the subcutaneous fat after lymphotropic administration of isoniazid: experimental study].
    Gedymin LE; Firsova VA; Gubkina MF
    Probl Tuberk; 1997; (2):51-4. PubMed ID: 9235595
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Albumin microspheres as a drug delivery system for dexamethasone: pharmaceutical and pharmacokinetic aspects.
    Dilova V; Shishkova V
    J Pharm Pharmacol; 1993 Nov; 45(11):987-9. PubMed ID: 7908043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aminophylline targeting to lung: optimization of the size and drug loading of albumin microspheres.
    Tripathi KP; Singh J
    J Microencapsul; 1992; 9(2):229-35. PubMed ID: 1593406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Study on the lung targeting gelatin microspheres of streptomycin sulphate].
    Zhang Z; Lu B; Shu G; Xie H; Yi Q; He Y; Wang J
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Jun; 26(2):167-71. PubMed ID: 7490024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Research on in vitro release of Isoniazid (INH) super paramagnetic microspheres in different magnetic fields.
    Xie H; Huang H; He W; Fu Z; Luo C; Ashraf MA
    Pak J Pharm Sci; 2016 Nov; 29(6 Spec):2207-2212. PubMed ID: 28412681
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isoniazid overdose.
    Eidus L; Hodgkin MM
    Can Med Assoc J; 1978 Oct; 119(7):692,694. PubMed ID: 709466
    [No Abstract]   [Full Text] [Related]  

  • 51. In vitro release profile of mitomycin C from albumin microspheres: extrapolation from macrospheres to microspheres.
    Natsume H; Sugibayashi K; Morimoto Y
    Pharm Res; 1991 Feb; 8(2):185-90. PubMed ID: 1902563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of stabilization temperature on the degradation of adriamycin in albumin microspheres.
    Law SL; Chiang CH; Lin FM; Teh GW
    Biomater Artif Cells Immobilization Biotechnol; 1991; 19(3):613-29. PubMed ID: 1760494
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Albumin microspheres: heat and chemical stabilization.
    Yapel AF
    Methods Enzymol; 1985; 112():1-18. PubMed ID: 4046842
    [No Abstract]   [Full Text] [Related]  

  • 54. [Formula for calculating the effective dose of isoniazid].
    Nouhouayi A
    Dakar Med; 1980; 25(4):272-6. PubMed ID: 7227147
    [No Abstract]   [Full Text] [Related]  

  • 55. Controlled release hydrophilic matrix tablet formulations of isoniazid: design and in vitro studies.
    Hiremath PS; Saha RN
    AAPS PharmSciTech; 2008; 9(4):1171-8. PubMed ID: 19015997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preparation of targeted isoniazid microspheres.
    Bosela AA; el-Sayed MM; Mahmoud MI
    Boll Chim Farm; 1998 Mar; 137(3):77-81. PubMed ID: 9611845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biodegradable implants from poly-(alpha-hydroxy acid) polymers for isoniazid delivery.
    Hurley L; Andersen BR
    Int J Tuberc Lung Dis; 1999 Nov; 3(11):1015-24. PubMed ID: 10587324
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dissolution test for site-specific release isoniazid pellets in USP apparatus 3 (reciprocating cylinder): optimization using response surface methodology.
    Joshi A; Pund S; Nivsarkar M; Vasu K; Shishoo C
    Eur J Pharm Biopharm; 2008 Jun; 69(2):769-75. PubMed ID: 18191554
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ofloxacin targeting to lungs by way of microspheres.
    Harsha S; R C; Rani S
    Int J Pharm; 2009 Oct; 380(1-2):127-32. PubMed ID: 19646516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.